Muutke küpsiste eelistusi

E-raamat: Valuing Health for Regulatory Cost-Effectiveness Analysis

  • Formaat: 382 pages
  • Ilmumisaeg: 28-Apr-2006
  • Kirjastus: National Academies Press
  • Keel: eng
  • ISBN-13: 9780309657006
  • Formaat - PDF+DRM
  • Hind: 59,80 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: 382 pages
  • Ilmumisaeg: 28-Apr-2006
  • Kirjastus: National Academies Press
  • Keel: eng
  • ISBN-13: 9780309657006

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

Promoting human health and safety by reducing exposures to risks and harms through regulatory interventions is among the most important responsibilities of the government. Such efforts encompass a wide array of activities in many different contexts: improving air and water quality; safeguarding the food supply; reducing the risk of injury on the job, in transportation, and from consumer products; and minimizing exposure to toxic chemicals. Estimating the magnitude of the expected health and longevity benefits and reductions in mortality, morbidity, and injury risks helps policy makers decide whether particular interventions merit the expected costs associated with achieving these benefits and inform their choices among alternative strategies. Valuing Health for Regulatory Cost-Effectiveness Analysis provides useful recommendations for how to measure health-related quality of- life impacts for diverse public health, safety, and environmental regulations. Public decision makers, regulatory analysts, scholars, and students in the field will find this an essential review text. It will become a standard reference for all government agencies and those consultants and contractors who support the work of regulatory programs.Table of Contents



Front Matter Executive Summary 1 Introduction 2 Characteristics of Major Regulations and Current Analytic Practices 3 Measures and Strategies for Obtaining Health Benefit Values for Regulatory Analysis 4 Beyond Ratios: Ethical and Nonquantifiable Aspects of Regulatory Decisions 5 Recommendations for Regulatory Cost-Effectiveness Analysis Appendix A Summary of Case Studies Appendix B Health Indexes Appendix C OMB Circular A-4 Appendix D Acronyms and Glossary Appendix E Biographical Sketches References Index
EXECUTIVE SUMMARY 1(14)
1 INTRODUCTION 15(26)
The Charge to the Committee,
16(3)
The Role of Economic Analysis in Regulatory Development,
19(7)
Benefit–Cost and Cost-Effectiveness Analysis,
26(14)
Organization of the Report,
40(1)
2 CHARACTERISTICS OF MAJOR REGULATIONS AND CURRENT ANALYTIC PRACTICES 41(26)
Types of Risk Regulations,
41(9)
Current Practices for Regulatory Analysis,
50(15)
Summary,
65(2)
3 MEASURES AND STRATEGIES FOR OBTAINING HEALTH BENEFIT VALUES FOR REGULATORY ANALYSIS 67(63)
Criteria for Selecting HALY Metrics for Regulatory CEA,
68(4)
Single-Dimension Measures of Health-Related Outcomes,
72(1)
Health-Adjusted Life Years,
73(19)
Sources of Health State Values for Regulatory Analysis,
92(31)
Research and Development of Metrics and Valuation Methodologies,
123(2)
Summary and Conclusions,
125(5)
4 BEYOND RATIOS: ETHICAL AND NONQUANTIFIABLE ASPECTS OF REGULATORY DECISIONS 130(29)
Ethical Assumptions in QALY-Based CEA,
132(8)
Ethical and Other Implications of Risks and of Interventions to Address Risks,
140(4)
Distributional Concerns about Risks and Regulatory Interventions,
144(11)
Improving Regulatory Decision Making,
155(2)
Conclusions,
157(2)
5 RECOMMENDATIONS FOR REGULATORY COST-EFFECTIVENESS ANALYSIS 159(34)
Recommendations,
161(27)
Summary,
188(5)
APPENDIXES
A Summary of Case Studies
193(52)
B Health Indexes
245(9)
The Quality of Well-Being Scale,
245(2)
The Health Utilities Index Mark 2,
247(2)
The Health Utilities Index Mark 3,
249(3)
The EuroQoL-5D,
252(1)
The SF-6D,
253(1)
The Functional Capacity Index,
254(4)
C OMB Circular A-4
258(58)
D Acronyms and Glossary
316(10)
E Biographical Sketches
326(9)
REFERENCES 335(16)
INDEX 351


Wilhelmine Miller, Lisa A. Robinson, and Robert S. Lawrence, Editors, Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation